The FDA just approved Viramune (nevirapine)

July 1996

The FDA just approved Viramune (nevirapine)...the FIFTH new antiviral for HIV in just the last 6 months.

Viramune is the first drug in a new class called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It inhibits the same enzyme as AZT...but it works in a different way.

Experts don't yet know exactly how to use this drug.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote